Analysis of results of effective dose estimation obtained from RADAR 2017 dose assessment model for nuclear medicine procedures by Del Barco, L. et al.
Eur J Nucl Med Mol Imaging (2020) 47 (Suppl 1): S1–S753
EP-39




Yttrium-90 PET imaging with digital photon counting for 
radioembollization absorbed dose monitoring
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Aim/Introduction: We investigated the accuracy of image-
based 90Y PET dosimetry quantification with a SiPM-based 
PET/CT for radioembolization dose monitoring purposes. 
Different image reconstruction protocols from published 
studies [1,2] were used to compare with the clinical protocol 
in our centre. Materials and Methods: Three 90Y phantoms 
were imaged: (1) a NEMA NU 2-1994 PET phantom with an 
insert filled with an uniform activity concentration (AC) = 
1.71 MBq/mL, (2) a cylindrical phantom with AC = 0.29 MBq/
mL, and (3) a NEMA body phantom containing six spheres 
of varying diameters (10-37 mm), with AC = 2.18 MBq/
mL in all spheres and a sphere-to-background ratio of 9:1. 
Listmode PET data were acquired with a Philips Vereos 
digital photon counting (DPC)-PET/CT for 15 minutes in a 
single-bed position. Images were reconstructed using OSEM 
iterative algorithm with 3 iterations, 5 subsets, time-of-
flight (ToF) and point-spread function (PSF). 2mm full-width 
at half-maximum (FWHM) Gaussian post-reconstruction 
filter was applied to all reconstructions. Phantoms (1) and 
(2), less influenced by partial-volume effects, were used 
for absolute quantification measurements. Phantom (3) 
was used to determine the AC recovery coefficients (RCs) 
of the hot spheres and background, based on CT-defined 
VOIs. We compared the results with those obtained from 
reconstruction parameters proposed by [1] (1 iteration, 21 
subsets, ToF, PSF, 4.5mm FWHM filter) and [2] (3 iterations, 
12 subsets, ToF, PSF, 5.2mm FWHM filter). Reconstructions 
were also performed with only the first 11 minutes of the 
acquisitions. Results: The relative differences between the 
reference and measured ACs in phantoms (1) and (2) were 
less than 1.5% and 2.5%, respectively. RCs for the hot spheres 
in phantom (3) for all reconstruction sets were between 0.74-
0.78, 0.71-0.78 and 0.3-0.4 for the 37, 22 and 13mm spheres, 
respectively. RCs for the background using our parameters 
and the ones from [1] and [2] were 0.96, 0.86 and 0.94, 
respectively. RCs obtained with 11-minutes reconstructions 
were within 5% of the 15-minutes ones. ACs standard 
deviations were below 0.8 MBq/mL for the hot spheres. 
Conclusion: Reconstructions using 3 iterations provided 
overall better RCs than 1 iteration. Acquisition duration could 
be reduced by 30% (15 to 11 minutes) without accuracy 
degradation, thus improving patient comfort. References: 
[1]Pasciak et al. “A comparison of techniques for 90Y PET/
CT image-based dosimetry following radioembolization 
with resin microspheres.” Frontiers in Oncology 4(2014): 121 
[2]Siman et al. “Dose volume histogram-based optimization 
of image reconstruction parameters for quantitative 
90Y-PET imaging.” Medical Physics 46.1(2019): p.229-237
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Analysis of results of effective dose estimation obtained 
from RADAR 2017 dose assessment model for nuclear 
medicine procedures
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Aim/Introduction: To analyze the results of effective dose (E) 
estimation of the most frequent procedures using photon 
emitters in Nuclear Medicine, obtained from RADAR 2017 
dose assessment model. To compare these results with 
those obtained from ICRP 128 (2015) recommendations, 
and to assess how using each dose assessment model can 
change E results. Materials and Methods: E estimation data 
was collected from photon emitter procedures performed 
during the last year in our department, obtained from 
RADAR 2017 dose estimation model for age groups: ≤ 1 
year old; >1-5 years old ; >5- 10 years old, >10- 15 years old 
and adults. Injected activity was the one recommended by 
international guidelines and EANM Pediatric and Dosimetry 
Committees. Hybrid exams (SPECT / CT) and procedures for 
which there is no RADAR 2017 dosimetry estimation were 
excluded. Results for (E) were compared with those obtained 
by using ICRP 128 (2015) recommendations. Results: With 
RADAR 2017 dose evaluation model we obtained a lower 
mean value of E on most of the procedures that were 
analyzed, being significantly lower for Renogram, Renal 
scintigraphy on >10-15 years old, Thyroid scintigraphy, 
Meckel’s scan and Bone Scan (0.12 to 1.16 mSv, 25% to 
67%). Brain perfusion and Renal scintigraphy on ages under 
10 obtained a significantly greater difference for E (0.33 
to 2.85 mSv, 26% to 29%). Conclusion: These results are 
an updated collection of estimated E values for photon-
S654
emitting radiopharmaceuticals commonly used in Nuclear 
Medicine, considering RADAR 2017 dose assessment model 
compared to ICRP 128) recommendations. Methodological 
changes on estimation lead to lower E for most of diagnostic 
procedures using photon emitters, this is of special interest 
for patients undergoing repeated ionizing radiation 
(dosimetry history). References: None
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Patient Radiation Doses from hybrid NM/CT Scans: 
Manitoba, Canada Vs. Europe
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Aim/Introduction: This study documented patient radiation 
doses from common clinical hybrid nuclear medicine 
/ computed tomography (NM/CT) procedures in the 
Canadian province of Manitoba (population 1.34 million). 
Results were compared to European values and used 
to establish diagnostic reference levels (DRLs). Materials 
and Methods: All hybrid NM/CT facilities in Manitoba 
participated, comprising of eight SPECT/CT systems and 
one PET/CT system. Data were collected for six clinical 
SPECT/CT procedures and three PET/CT procedures: Bone 
(Torso only), Myocardial Perfusion, Lung V/Q, Parathyroid, 
Octreotide, Sentinel Lymph Node / Melanoma Mapping, 
then PET/CT brain, Near Whole Body(NWB), and Head/
Neck (H/N) + NWB. DLP (mGy∙cm) and administered 
activity (MBq) data were collected for 10-20 patients 
weighing 70+/- 20kg. Paediatric and pregnant patients 
were excluded. Comparison was drawn to relevant values 
presented in recent European publications. Results: 
Provincial CT DRLs have been established for the following 
procedures; Bone (190 mGy.cm), Cardiac MPS (55 mGy.cm), 
Lung V/Q (140 mGy.cm), Parathyroid (115 mGy.cm), and In-
111 Octreotide (155 mGy.cm) SPECT/CT procedures. Site 
DRLs were established for the following PET/CT procedures; 
Near Whole Body (NWB 335 mGy.cm), H/N + NWB (525 
mGy.cm), and Brain (645 mGy.cm). Provincial NM DRLs were 
calculated for Bone (815 MBq), Cardiac MPS (1490 MBq), 
Lung V/Q (40/210 MBq), Parathyroid (785 MBq MIBI), and In-
111 Octreotide (135 MBq) SPECT/CT procedures. Site DRLs 
were calculated for all F-18 FDG PET/CT procedures; NWB 
or H/N +NWB (435 MBq), and Brain (270 MBq). The Sentinel 
Lymph Node/Melanoma procedures were too varied to 
establish DRL values. These values are comparable to values 
published in the literature. CT DRL ranges observed were 
Bone (150-200mGy.cm), Cardiac MPS (36-70mGy.cm), Lung 
V/Q (100mGy.cm, perfusion only), Parathyroid (160-170mGy.
cm), In-111 Octreotide (240mGy.cm) and PET/CT NWB 
(400-750mGy.cm). For the radionuclide administration, the 
observed activity ranges were as follows; Bone (600-800 
MBq), Cardiac MPS (950-1600 MBq), Lung V/Q (40/120-200 
MBq), Parathyroid (700-900 MBq MIBI), In-111 Octreotide 
(220 MBq) F-18 FDG Near Whole Body PET (350-400 MBq), 
and F-18 FDG PET Brain (250 MBq). Conclusion: Several 
dose optimization opportunities were identified and are 
being pursued. For example, one system had average DLPs 
equal to or higher than the provincial DRL for all but cardiac 
studies, almost 1.5 times larger for parathyroid imaging, 
and double the DRL for octreotide imaging. Ongoing 
optimization work focuses on standardizing CT protocols. 
Results of the survey, comparison to European values and 
initial optimization efforts will be presented. References: 
None
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Quantification of myocardial dosimetry and glucose 
metabolism using a 17 segment model of the left 
ventricle in esophageal cancer patients receiving 
radiotherapy
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Medical University and Shandong, Jinan, CHINA, 2Turku 
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Aim/Introduction: Previous studies have shown that 
increased cardiac uptake of 18F-fluorodeoxyglucose (FDG) 
from positron emission tomography (PET) may be an 
indicator of myocardial injury after radiotherapy. The primary 
objective of this study was to quantify cardiac subvolume 
dosimetry and 18F- FDG uptake in oncologic PET using 
a17-segment model of the left ventricle (LV) and to identify 
dose limits related to changes in cardiac FDG uptake 
after radiotherapy (RT). Materials and Methods: Twenty-
four esophageal cancer (EC) patients who underwent 
consecutive oncologic 18F-FDG PET/CT scans at baseline 
and post-RT were enrolled in this study. The radiation dose 
and the 18F-FDG uptake were quantitatively analyzed 
based on a 17-segment model. The 18F-FDG uptake and 
doses to the basal, mid and apical regions, and the changes 
in the 18F-FDG uptake for different dose ranges were 
analyzed. Results: A heterogeneous dose distribution was 
observed, and the basal region received a higher median 
mean dose (18.36 Gy) than the middle and apical received 
the highest doses, all of which were greater than 10 Gy. 
Three patterns were observed for the myocardial 18F-FDG 
uptake related to the radiation dose before and after RT: 
an increase (5 patients), a decrease (13 patients) and no 
change (6 patients). In the pairing analysis, the 18F-FDG 
uptake after RT decreased by 28.93% and 12.12% in the 
low-dose segments (0-10 Gy and 10-20 Gy,respectively) 
and increased by 7.24% in the high-dose segments (20-30 
Gy). Conclusion: The RT dose varies substantially within LV 
segments in patients receiving thoracic EC RT. Increased 
18F-FDG uptake in the myocardium after RT was observed 
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